Today - January 4, 2024
Thomas Ullman, M.D., explains how he treats patients with ulcerative colitis and how they can manage their condition to minimize its effects. Dr Ullman is professor of medicine at Einstein, chief of the division of gastroenterology, and a gastroenterologist at Montefiore.
Dr. Ullman's Profile
MedPageToday - January 2, 2024
An opinion piece on artificial intelligence quotes an Einstein Doctor's Tablet blog by Simon Spivack, M.D., M.P.H., who writes that technology cannot replace the necessary human connection between patients and physicians. Dr. Spivack is professor of medicine, of epidemiology & population health, and of genetics at Einstein, and a pulmonologist at Montefiore.
Dr. Spivack's ProfileMore coverage on Dr. Spivack
Science News - December 8, 2023
Kerry Morrone, M.D., talks about the benefits of a new CRISPR treatment for sickle-cell disease and the importance of ensuring health equity for patients around the world who need treatment and care. Dr. Morrone is assistant professor of pediatrics at Einstein and director of the Sickle-Cell Program at the Children's Hospital at Montefiore.
Dr. Morrone's ProfileMore coverage on Dr. Morrone
The New York Times - December 5, 2023
Jelena Pavlovic, M.D., Ph.D., talks about the link between estrogen levels and migraine in women, noting that the start and timing of headaches for many women is connected with a drop in their estrogen, which occurs before and during menstruation. Dr. Pavolovic is associate professor in the Saul R. Korey Department of Neurology at Einstein and a neurologist at Montefiore.
Dr. Pavlovic's Profile
Live Science - December 1, 2023
Anjali Sharma, M.D., M.S., says access to antiretroviral therapy for HIV/AIDS, particularly for young people, and support systems for those on treatment are essential to ending the global AIDS epidemic. Dr. Sharma is professor of medicine at Einstein and an internist at Montefiore.
Dr. Sharma's Profile
NPR - November 29, 2023
Rahil Briggs, Psy.D., and Kevin Fiori, M.D., M.P.H., M.S., discuss the importance of HealthySteps, a program that supports low-income parents' psychological and social needs. Dr. Briggs is clinical professor of pediatrics and psychiatry & behavioral sciences at Einstein and national director of HealthySteps. Dr. Fiori is associate professor of pediatrics and of family & social medicine at Einstein and a pediatrician and director, social determinants of health, in the office of community & population health at Montefiore.
Dr. Briggs' ProfileMore coverage on Dr. Briggs
Dr. Fiori's Profile
Fortune - November 16, 2023
Nir Barzilai, M.D., and Sofiya Milman, M.D., M.S., describe their SuperAgers Family Study, which seeks to discover genes that contribute to healthy aging. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. Dr. Milman is associate professor of medicine and of genetics and director of Human Longevity Studies at Einstein’s Institute for Aging Research and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Dr. Milman's ProfileMore coverage on Dr. Milman
NPR - October 30, 2023
Gary Schwartz, Ph.D., describes how GLP-1, a hormone that is released during digestion, acts to stimulate insulin and slow how quickly food moves through the stomach into the intestine. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
MedPageToday - October 16, 2023
Sriram Machineni, M.B.B.S., comments on the results of a study he co-authored on the effectiveness of a phase III trial for tirzepatide, a weight loss drug, which helped study participants lose a significant amount of weight following a diet and exercise program. Dr. Machineni is associate professor of medicine and director of the Fleischer Institute Medical Weight Center at Einstein and Montefiore.
Additional coverage includes Medscape
Dr. Machineni's Profile
US News & World Report - October 16, 2023
Tracey Straker, M.D., comments on a study that found high-risk surgeries are more deadly for Black and Hispanic Americans than their white counterparts, noting that social determinants of health, such as lack of insurance, play a role in the disparities. Dr. Straker is professor and chief of anesthesiology at Einstein and Montefiore.
Dr. Straker's ProfileMore coverage on Dr. Straker
Medscape - October 12, 2023
Belinda Ostrowsky, M.D., says wastewater monitoring of viruses and other seasonal illnesses can be helpful to local public health officials, clinicians, and hospital systems because it provides insight into viral trends at the community level. Dr. Ostrowsky is clinical associate professor of medicine at Einstein.
Dr. Ostrowsky's ProfileMore coverage on Dr. Ostrowsky
USA Today - October 1, 2023
Shivani Agarwal, M.D., M.P.H., discusses a study she led that found structural issues, such as poverty, racism, and unequal access to healthy food and high-quality medical care, contribute to the high rates of diabetes around the world. Dr. Agarwal is associate professor of medicine and associate director of the Fleischer Institute for Diabetes and Metabolism at Einstein and an endocrinologist at Montefiore.
Dr. Agarwal's ProfileMore coverage on Dr. Agarwal
Fox5 - September 28, 2023
Shelby Freedman Harris, Psy.D., says muscle relaxation, deep breathing, keeping a regular sleep schedule, and having a relaxing bedtime routine may help improve sleep quality and quantity. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.
Dr. Harris' ProfileMore coverage on Dr. Harris
The Washington Post - September 26, 2023
Jonathan Alpert, M.D., Ph.D., warns against self-medicating with psychedelics for depression or other mental health disorders, noting that patients need to be evaluated and under the care of trained providers if psychedelics are used in their treatment. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski